In AD patients, extracellular amyloid-β plaques and intracellular tau protein accumulation activate microglia, triggering chronic inflammation and neuronal death (Sato et al., 2018), which results in cognitive impairment. The gene discussed is MAPT; the disease is Alzheimer disease.